XML 36 R25.htm IDEA: XBRL DOCUMENT v3.19.2
Fair value measurements (Tables)
6 Months Ended
Jun. 30, 2019
Fair Value Disclosures [Abstract]  
Financial Instruments Measured At Fair Value On A Recurring Basis
Financial instruments measured at fair value on a recurring basis, by valuation hierarchy
June 30, 2019
Level 1

 
Level 2

 
Level 3

 
Total

(in millions of U.S. dollars)
 
 
 
Assets:
 
 
 
 
 
 
 
Fixed maturities available for sale
 
 
 
 
 
 
 
U.S. Treasury and agency
$
2,934

 
$
706

 
$

 
$
3,640

Foreign

 
22,277

 
371

 
22,648

Corporate securities

 
28,375

 
1,359

 
29,734

Mortgage-backed securities

 
17,890

 
76

 
17,966

States, municipalities, and political subdivisions

 
8,422

 

 
8,422

 
2,934

 
77,670

 
1,806

 
82,410

Equity securities
659

 

 
56

 
715

Short-term investments
2,360

 
1,444

 
4

 
3,808

Other investments (1)
414

 
353

 
11

 
778

Securities lending collateral

 
1,727

 

 
1,727

Investment derivative instruments
15

 

 

 
15

Other derivative instruments
15

 

 

 
15

Separate account assets
3,109

 
137

 

 
3,246

Total assets measured at fair value (1)
$
9,506

 
$
81,331

 
$
1,877

 
$
92,714

Liabilities:
 
 
 
 
 
 
 
Investment derivative instruments
$
60

 
$
104

 
$

 
$
164

Other derivative instruments
10

 

 

 
10

GLB (2)

 

 
403

 
403

Total liabilities measured at fair value
$
70

 
$
104

 
$
403

 
$
577

(1) 
Excluded from the table above are partially-owned investments, investment funds, and limited partnerships of $4,860 million and other investments of $89 million at June 30, 2019 measured using NAV as a practical expedient.
(2) 
Our GLB reinsurance product meets the definition of a derivative instrument for accounting purposes and is accordingly carried at fair value. Excluded from the table above is the portion of the GLB derivative liability classified as Future policy benefits in the Consolidated balance sheets.
 
December 31, 2018
Level 1

 
Level 2

 
Level 3

 
Total

(in millions of U.S. dollars)
 
 
 
Assets:
 
 
 
 
 
 
 
Fixed maturities available for sale
 
 
 
 
 
 
 
U.S. Treasury and agency
$
3,400

 
$
745

 
$

 
$
4,145

Foreign

 
21,071

 
345

 
21,416

Corporate securities

 
25,284

 
1,299

 
26,583

Mortgage-backed securities

 
15,479

 
61

 
15,540

States, municipalities, and political subdivisions

 
10,786

 

 
10,786

 
3,400

 
73,365

 
1,705

 
78,470

Equity securities
713

 

 
57

 
770

Short-term investments
1,575

 
1,440

 
1

 
3,016

Other investments (1)
381

 
303

 
11

 
695

Securities lending collateral

 
1,926

 

 
1,926

Investment derivative instruments
28

 

 

 
28

Other derivative instruments
25

 

 

 
25

Separate account assets
2,686

 
137

 

 
2,823

Total assets measured at fair value (1)
$
8,808

 
$
77,171

 
$
1,774

 
$
87,753

Liabilities:
 
 
 
 
 
 
 
Investment derivative instruments
$
38

 
$
115

 
$

 
$
153

GLB (2)

 

 
452

 
452

Total liabilities measured at fair value
$
38

 
$
115

 
$
452

 
$
605


(1) 
Excluded from the table above are partially-owned investments, investment funds, and limited partnerships of $4,244 million and other investments of $95 million at December 31, 2018 measured using NAV as a practical expedient.
(2) 
Our GLB reinsurance product meets the definition of a derivative instrument for accounting purposes and is accordingly carried at fair value. Excluded from the table above is the portion of the GLB derivative liability classified as Future policy benefits in the Consolidated balance sheets.
Fair Value And Maximum Future Funding Commitments Related To Investments The following table presents, by investment category, the expected liquidation period, fair value, and maximum future funding commitments of alternative investments:
 
 
 
 
 
June 30

 
 
 
December 31

 
Expected
Liquidation
Period of Underlying Assets
 
 
 
2019

 
 
 
2018

(in millions of U.S. dollars)
Fair
Value

 
Maximum
Future Funding
Commitments

 
Fair
Value

 
Maximum
Future Funding
Commitments

Financial
2 to 10 Years
 
$
575

 
$
375

 
$
596

 
$
193

Real Assets
2 to 11 Years
 
776

 
542

 
704

 
362

Distressed
2 to 7 Years
 
267

 
93

 
296

 
105

Private Credit
3 to 8 Years
 
116

 
269

 
147

 
310

Traditional
2 to 14 Years
 
2,741

 
2,257

 
2,362

 
2,735

Vintage
1 to 2 Years
 
122

 
39

 
56

 

Investment funds
Not Applicable
 
263

 

 
83

 

 
 
 
$
4,860

 
$
3,575

 
$
4,244

 
$
3,705


Schedule Of Significant Unobservable Inputs Used In Level 3 Liability Valuations
The following table presents the significant unobservable inputs used in the Level 3 liability valuations. Excluded from the table below are inputs used to determine the fair value of Level 3 assets which are based on single broker quotes and contain no quantitative unobservable inputs developed by management. The majority of our fixed maturities classified as Level 3 used external pricing when markets are less liquid due to the lack of market inputs (i.e., stale pricing, broker quotes).
(in millions of U.S. dollars, except for percentages)
Fair Value
 
 
Valuation
Technique
 
Significant
Unobservable Inputs
 
Ranges
June 30, 2019

 
December 31, 2018

 
 
 
GLB (1)
$
403

 
$
452

 
Actuarial model
 
Lapse rate
 
3% – 32%
 
 
 
 
 
 
 
Annuitization rate
 
0% – 42%
(1) 
Discussion of the most significant inputs used in the fair value measurement of GLB and the sensitivity of those assumptions is included within Note 3 a) Guaranteed living benefits.
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]
The following tables present a reconciliation of the beginning and ending balances of financial instruments measured at fair value using significant unobservable inputs (Level 3):
 
Assets
 
Liabilities
 
Three Months Ended
Available-for-Sale Debt Securities
Equity
securities

 
Short-term investments

 
Other
investments

 
GLB (1)

June 30, 2019
Foreign

 
Corporate
securities

 
MBS

 
(in millions of U.S. dollars)
 
 
 
Balance – beginning of period
$
360

 
$
1,342

 
$
78

 
$
55

 
$

 
$
11

 
$
338

Transfers into Level 3

 
10

 

 

 

 

 

Transfers out of Level 3

 

 

 

 

 

 

Change in Net Unrealized Gains (Losses) included in OCI, including foreign exchange

 
1

 

 
1

 

 

 

Net Realized Gains/Losses

 
(1
)
 

 
(1
)
 

 

 
65

Purchases
43

 
121

 

 
5

 
4

 

 

Sales
(14
)
 
(36
)
 
(1
)
 
(4
)
 

 

 

Settlements
(18
)
 
(78
)
 
(1
)
 

 

 

 

Balance – end of period
$
371

 
$
1,359

 
$
76

 
$
56

 
$
4

 
$
11

 
$
403

Net Realized Gains/Losses Attributable to Changes in Fair Value at the Balance Sheet Date
$

 
$
(1
)
 
$

 
$
(1
)
 
$

 
$

 
$
65


(1) 
Our GLB reinsurance product meets the definition of a derivative instrument for accounting purposes and is accordingly carried at fair value. Excluded from the table above is the portion of the GLB derivative liability classified as Future policy benefits in the Consolidated balance sheets. The liability for GLB reinsurance was $815 million at June 30, 2019, and $741 million at March 31, 2019, which includes a fair value derivative adjustment of $403 million and $338 million, respectively.
  
Assets
 
 
 
 
Liabilities

Three Months Ended
Available-for-Sale Debt Securities
 
 
Equity
securities

 
Short-term investments

 
Other
investments

 
Other derivative instruments

 
GLB (2)

June 30, 2018
Foreign

 
Corporate securities (1)

 
MBS

 
 
(in millions of U.S. dollars)
 
 
 
 
Balance – beginning of period
$
176

 
$
1,073

 
$
83

 
$
64

 
$
12

 
$
270

 
$
2

 
$
167

Transfers into Level 3

 
6

 

 

 

 

 

 

Transfers out of Level 3

 

 

 

 

 

 

 

Change in Net Unrealized Gains (Losses) included in OCI, including foreign exchange
(7
)
 
(9
)
 

 

 

 

 

 

Net Realized Gains/Losses

 
2

 

 
(3
)
 

 
1

 

 
(42
)
Purchases
95

 
217

 

 
3

 
1

 
16

 

 

Sales
(11
)
 
(45
)
 

 
(5
)
 

 

 

 

Settlements
(1
)
 
(63
)
 
(1
)
 

 
(1
)
 
(23
)
 

 

Balance – end of period
$
252

 
$
1,181

 
$
82

 
$
59

 
$
12

 
$
264

 
$
2

 
$
125

Net Realized Gains/Losses Attributable to Changes in Fair Value at the Balance Sheet Date
$

 
$

 
$

 
$
(3
)
 
$

 
$
1

 
$

 
$
(42
)
(1) 
Purchases in Level 3 primarily consist of privately-placed fixed income securities.
(2) 
Our GLB reinsurance product meets the definition of a derivative instrument for accounting purposes and is accordingly carried at fair value. Excluded from the table above is the portion of the GLB derivative liability classified as Future policy benefits in the Consolidated balance sheets. The liability for GLB reinsurance was $497 million at June 30, 2018, and $529 million at March 31, 2018, which includes a fair value derivative adjustment of $125 million and $167 million, respectively.


 
Assets
 
Liabilities
 
Six Months Ended
Available-for-Sale Debt Securities
 
 
Equity
securities

 
Short-term investments

 
Other
investments

 
GLB (1)

June 30, 2019
Foreign

 
Corporate
securities

 
MBS

 
(in millions of U.S. dollars)
 
 
 
Balance – beginning of period
$
345

 
$
1,299

 
$
61

 
$
57

 
$
1

 
$
11

 
$
452

Transfers into Level 3
3

 
15

 

 

 

 

 

Transfers out of Level 3
(15
)
 

 

 

 

 

 

Change in Net Unrealized Gains (Losses) included in OCI, including foreign exchange
6

 
5

 

 
2

 

 

 

Net Realized Gains/Losses
(1
)
 

 

 
(3
)
 

 

 
(49
)
Purchases
96

 
249

 
18

 
14

 
4

 


 

Sales
(19
)
 
(73
)
 
(1
)
 
(14
)
 

 

 

Settlements
(44
)
 
(136
)
 
(2
)
 

 
(1
)
 

 

Balance – end of period
$
371

 
$
1,359

 
$
76

 
$
56

 
$
4

 
$
11

 
$
403

Net Realized Gains/Losses Attributable to Changes in Fair Value at the Balance Sheet Date
$

 
$
(1
)
 
$

 
$
(2
)
 
$

 
$

 
$
(49
)
(1) 
Our GLB reinsurance product meets the definition of a derivative instrument for accounting purposes and is accordingly carried at fair value. Excluded from the table above is the portion of the GLB derivative liability classified as Future policy benefits in the Consolidated balance sheets. The liability for GLB reinsurance was $815 million at June 30, 2019, and $861 million at December 31, 2018, which includes a fair value derivative adjustment of $403 million and $452 million, respectively.
  
Assets
 
 
 
 
Liabilities

Six Months Ended
Available-for-Sale Debt Securities
 
 
Equity
securities

 
Short-term investments

 
Other
investments

 
Other derivative instruments

 
GLB (2)

June 30, 2018
Foreign

 
Corporate securities (1)

 
MBS

 
 
 
 
(in millions of U.S. dollars)
 
 
 
 
 
 
Balance – beginning of period
$
93

 
$
1,037

 
$
78

 
$
44

 
$

 
$
263

 
$
2

 
$
204

Transfers into Level 3
7

 
6

 
1

 

 
5

 

 

 

Transfers out of Level 3

 
(10
)
 

 

 

 

 

 

Change in Net Unrealized Gains (Losses) included in OCI, including foreign exchange
2

 
(12
)
 

 
1

 

 
2

 

 

Net Realized Gains/Losses

 
2

 

 
(1
)
 

 
1

 

 
(79
)
Purchases
182

 
356

 
4

 
20

 
9

 
30

 

 

Sales
(30
)
 
(96
)
 

 
(5
)
 

 

 

 

Settlements
(2
)
 
(102
)
 
(1
)
 

 
(2
)
 
(32
)
 

 

Balance – end of period
$
252

 
$
1,181

 
$
82

 
$
59

 
$
12

 
$
264

 
$
2

 
$
125

Net Realized Gains/Losses Attributable to Changes in Fair Value at the Balance Sheet Date
$

 
$

 
$

 
$
(1
)
 
$

 
$
1

 
$

 
$
(79
)
(1) 
Purchases in Level 3 primarily consist of privately-placed fixed income securities.
(2) 
Our GLB reinsurance product meets the definition of a derivative instrument for accounting purposes and is accordingly carried at fair value. Excluded from the table above is the portion of the GLB derivative liability classified as Future policy benefits in the Consolidated balance sheets. The liability for GLB reinsurance was $497 million at June 30, 2018, and $550 million at December 31, 2017, which includes a fair value derivative adjustment of $125 million and $204 million, respectively.


Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]
The following tables present a reconciliation of the beginning and ending balances of financial instruments measured at fair value using significant unobservable inputs (Level 3):
 
Assets
 
Liabilities
 
Three Months Ended
Available-for-Sale Debt Securities
Equity
securities

 
Short-term investments

 
Other
investments

 
GLB (1)

June 30, 2019
Foreign

 
Corporate
securities

 
MBS

 
(in millions of U.S. dollars)
 
 
 
Balance – beginning of period
$
360

 
$
1,342

 
$
78

 
$
55

 
$

 
$
11

 
$
338

Transfers into Level 3

 
10

 

 

 

 

 

Transfers out of Level 3

 

 

 

 

 

 

Change in Net Unrealized Gains (Losses) included in OCI, including foreign exchange

 
1

 

 
1

 

 

 

Net Realized Gains/Losses

 
(1
)
 

 
(1
)
 

 

 
65

Purchases
43

 
121

 

 
5

 
4

 

 

Sales
(14
)
 
(36
)
 
(1
)
 
(4
)
 

 

 

Settlements
(18
)
 
(78
)
 
(1
)
 

 

 

 

Balance – end of period
$
371

 
$
1,359

 
$
76

 
$
56

 
$
4

 
$
11

 
$
403

Net Realized Gains/Losses Attributable to Changes in Fair Value at the Balance Sheet Date
$

 
$
(1
)
 
$

 
$
(1
)
 
$

 
$

 
$
65


(1) 
Our GLB reinsurance product meets the definition of a derivative instrument for accounting purposes and is accordingly carried at fair value. Excluded from the table above is the portion of the GLB derivative liability classified as Future policy benefits in the Consolidated balance sheets. The liability for GLB reinsurance was $815 million at June 30, 2019, and $741 million at March 31, 2019, which includes a fair value derivative adjustment of $403 million and $338 million, respectively.
  
Assets
 
 
 
 
Liabilities

Three Months Ended
Available-for-Sale Debt Securities
 
 
Equity
securities

 
Short-term investments

 
Other
investments

 
Other derivative instruments

 
GLB (2)

June 30, 2018
Foreign

 
Corporate securities (1)

 
MBS

 
 
(in millions of U.S. dollars)
 
 
 
 
Balance – beginning of period
$
176

 
$
1,073

 
$
83

 
$
64

 
$
12

 
$
270

 
$
2

 
$
167

Transfers into Level 3

 
6

 

 

 

 

 

 

Transfers out of Level 3

 

 

 

 

 

 

 

Change in Net Unrealized Gains (Losses) included in OCI, including foreign exchange
(7
)
 
(9
)
 

 

 

 

 

 

Net Realized Gains/Losses

 
2

 

 
(3
)
 

 
1

 

 
(42
)
Purchases
95

 
217

 

 
3

 
1

 
16

 

 

Sales
(11
)
 
(45
)
 

 
(5
)
 

 

 

 

Settlements
(1
)
 
(63
)
 
(1
)
 

 
(1
)
 
(23
)
 

 

Balance – end of period
$
252

 
$
1,181

 
$
82

 
$
59

 
$
12

 
$
264

 
$
2

 
$
125

Net Realized Gains/Losses Attributable to Changes in Fair Value at the Balance Sheet Date
$

 
$

 
$

 
$
(3
)
 
$

 
$
1

 
$

 
$
(42
)
(1) 
Purchases in Level 3 primarily consist of privately-placed fixed income securities.
(2) 
Our GLB reinsurance product meets the definition of a derivative instrument for accounting purposes and is accordingly carried at fair value. Excluded from the table above is the portion of the GLB derivative liability classified as Future policy benefits in the Consolidated balance sheets. The liability for GLB reinsurance was $497 million at June 30, 2018, and $529 million at March 31, 2018, which includes a fair value derivative adjustment of $125 million and $167 million, respectively.


 
Assets
 
Liabilities
 
Six Months Ended
Available-for-Sale Debt Securities
 
 
Equity
securities

 
Short-term investments

 
Other
investments

 
GLB (1)

June 30, 2019
Foreign

 
Corporate
securities

 
MBS

 
(in millions of U.S. dollars)
 
 
 
Balance – beginning of period
$
345

 
$
1,299

 
$
61

 
$
57

 
$
1

 
$
11

 
$
452

Transfers into Level 3
3

 
15

 

 

 

 

 

Transfers out of Level 3
(15
)
 

 

 

 

 

 

Change in Net Unrealized Gains (Losses) included in OCI, including foreign exchange
6

 
5

 

 
2

 

 

 

Net Realized Gains/Losses
(1
)
 

 

 
(3
)
 

 

 
(49
)
Purchases
96

 
249

 
18

 
14

 
4

 


 

Sales
(19
)
 
(73
)
 
(1
)
 
(14
)
 

 

 

Settlements
(44
)
 
(136
)
 
(2
)
 

 
(1
)
 

 

Balance – end of period
$
371

 
$
1,359

 
$
76

 
$
56

 
$
4

 
$
11

 
$
403

Net Realized Gains/Losses Attributable to Changes in Fair Value at the Balance Sheet Date
$

 
$
(1
)
 
$

 
$
(2
)
 
$

 
$

 
$
(49
)
(1) 
Our GLB reinsurance product meets the definition of a derivative instrument for accounting purposes and is accordingly carried at fair value. Excluded from the table above is the portion of the GLB derivative liability classified as Future policy benefits in the Consolidated balance sheets. The liability for GLB reinsurance was $815 million at June 30, 2019, and $861 million at December 31, 2018, which includes a fair value derivative adjustment of $403 million and $452 million, respectively.
  
Assets
 
 
 
 
Liabilities

Six Months Ended
Available-for-Sale Debt Securities
 
 
Equity
securities

 
Short-term investments

 
Other
investments

 
Other derivative instruments

 
GLB (2)

June 30, 2018
Foreign

 
Corporate securities (1)

 
MBS

 
 
 
 
(in millions of U.S. dollars)
 
 
 
 
 
 
Balance – beginning of period
$
93

 
$
1,037

 
$
78

 
$
44

 
$

 
$
263

 
$
2

 
$
204

Transfers into Level 3
7

 
6

 
1

 

 
5

 

 

 

Transfers out of Level 3

 
(10
)
 

 

 

 

 

 

Change in Net Unrealized Gains (Losses) included in OCI, including foreign exchange
2

 
(12
)
 

 
1

 

 
2

 

 

Net Realized Gains/Losses

 
2

 

 
(1
)
 

 
1

 

 
(79
)
Purchases
182

 
356

 
4

 
20

 
9

 
30

 

 

Sales
(30
)
 
(96
)
 

 
(5
)
 

 

 

 

Settlements
(2
)
 
(102
)
 
(1
)
 

 
(2
)
 
(32
)
 

 

Balance – end of period
$
252

 
$
1,181

 
$
82

 
$
59

 
$
12

 
$
264

 
$
2

 
$
125

Net Realized Gains/Losses Attributable to Changes in Fair Value at the Balance Sheet Date
$

 
$

 
$

 
$
(1
)
 
$

 
$
1

 
$

 
$
(79
)
(1) 
Purchases in Level 3 primarily consist of privately-placed fixed income securities.
(2) 
Our GLB reinsurance product meets the definition of a derivative instrument for accounting purposes and is accordingly carried at fair value. Excluded from the table above is the portion of the GLB derivative liability classified as Future policy benefits in the Consolidated balance sheets. The liability for GLB reinsurance was $497 million at June 30, 2018, and $550 million at December 31, 2017, which includes a fair value derivative adjustment of $125 million and $204 million, respectively.


Carrying Values And Fair Values Of Financial Instruments Not Measured At Fair Value
The following tables present fair value, by valuation hierarchy, and carrying value of the financial instruments not measured at fair value:
June 30, 2019
Fair Value
 
 
Carrying Value

(in millions of U.S. dollars)
Level 1

 
Level 2

 
Level 3

 
Total

 
Assets:
 
 
 
 
 
 
 
 
 
Fixed maturities held to maturity
 
 
 
 
 
 
 
 
 
U.S. Treasury and agency
$
1,138

 
$
55

 
$

 
$
1,193

 
$
1,167

Foreign

 
1,523

 

 
1,523

 
1,465

Corporate securities

 
2,494

 
33

 
2,527

 
2,457

Mortgage-backed securities

 
2,502

 

 
2,502

 
2,442

States, municipalities, and political subdivisions

 
5,432

 

 
5,432

 
5,307

Total assets
$
1,138

 
$
12,006

 
$
33

 
$
13,177

 
$
12,838

Liabilities:
 
 
 
 
 
 
 
 
 
Repurchase agreements
$

 
$
1,416

 
$

 
$
1,416

 
$
1,416

Short-term debt

 
9

 

 
9

 
9

Long-term debt

 
14,541

 

 
14,541

 
13,371

Trust preferred securities

 
439

 

 
439

 
308

Total liabilities
$

 
$
16,405

 
$

 
$
16,405

 
$
15,104


December 31, 2018
Fair Value
 
 
Carrying Value

(in millions of U.S. dollars)
Level 1

 
Level 2

 
Level 3

 
Total

 
Assets:
 
 
 
 
 
 
 
 
 
Fixed maturities held to maturity
 
 
 
 
 
 
 
 
 
U.S. Treasury and agency
$
1,128

 
$
54

 
$

 
$
1,182

 
$
1,185

Foreign

 
1,542

 

 
1,542

 
1,549

Corporate securities

 
2,477

 
31

 
2,508

 
2,601

Mortgage-backed securities

 
2,486

 

 
2,486

 
2,524

States, municipalities, and political subdivisions

 
5,541

 

 
5,541

 
5,576

Total assets
$
1,128


$
12,100


$
31


$
13,259


$
13,435

Liabilities:
 
 
 
 
 
 
 
 
 
Repurchase agreements
$

 
$
1,418

 
$

 
$
1,418

 
$
1,418

Short-term debt

 
516

 

 
516

 
509

Long-term debt

 
12,181

 

 
12,181

 
12,087

Trust preferred securities

 
409

 

 
409

 
308

Total liabilities
$

 
$
14,524

 
$

 
$
14,524

 
$
14,322